News, features, and commentary about cancer-related issues ...

Robert F. Kennedy Jr. and his subordinates want Americans to have more conversations with their physicians. But they also can ...

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

An update from Profound Medical ( (TSE:PRN) ) is now available.

Axogen, Inc. (AXGN) 47th Annual Raymond James Institutional Investor Conference March 3, 2026 3:25 PM ESTCompany ParticipantsMichael Dale - President, ...

TD Cowen 46th Annual Health Care Conference March 2, 2026 11:50 AM ESTCompany ParticipantsLarry Wood - President, ...

The "Exosome Diagnostic and Therapeutics Market - Growth, Share, Opportunities & Competitive Analysis, 2025 - 2032" report has been added to the Credence ...